AnaptysBio, Inc. (ANAB) vs Maze Therapeutics, Inc. (MAZE)
- AnaptysBio, Inc. ANAB 46.61 −4.31%
- Maze Therapeutics, Inc. MAZE 27.53 +0.18%
AnaptysBio, Inc. and Maze Therapeutics, Inc. are both Biotechnology companies. AnaptysBio, Inc. and Maze Therapeutics, Inc. are of similar size ($1.5B and $1.5B). Maze Therapeutics, Inc. has the higher net margin (0.00% vs −11.5%) and the lower return on invested capital (−112.4% vs 0.00%). Across the 13 metrics below, AnaptysBio, Inc. leads on 9 and Maze Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ANAB | MAZE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | 17.56% | 0.00% | 0.00% |
| Net margin | (11.53%) | 0.00% | 0.00% |
| Free cash flow margin | 1.90% | 0.00% | 0.00% |
| Return on equity | (114.55%) | (37.35%) | (56.36%) |
| Return on assets | (7.13%) | (31.99%) | (48.04%) |
| Return on invested capital | 0.00% | (112.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack